# Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

> **NCT00316927** · PHASE3 · COMPLETED · sponsor: **St. Bartholomew's Hospital** · enrollment: 260 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** acetylsalicylic acid
- **DRUG:** dexamethasone
- **DRUG:** diethylstilbestrol

## Key facts

- **NCT ID:** NCT00316927
- **Lead sponsor:** St. Bartholomew's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316927, "Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00316927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*